// App-Quantinova.ai

3981 : In situ mass spectrometry using desorption electrospray ionization mass spectrometry (DESI-MS) can detect specific lipid profiles across breast cancer molecular subtypes

Researchers

Presenter

  • Victor P. Andrade

Principal Investigators

  • Adriana L. Santoro

  • Sabrina T. Moretti

  • Nicolas V. Schwab

  • Marcos N. Eberlin

Medical Centers

  • A.C. Camargo Cancer Center, Sao Paulo, Brazil

  • ThoMSon Mass Spectrometry Laboratory, UNICAMP, Campinas, Brazil.

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Proliferation marker protein Ki-67

  • erb-b2 receptor tyrosine kinase 2

  • Tumor protein p63

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved